Sanjivani Paranteral Limited share price
BSE: SANJIVIN
Key numbers
- Market cap
- ₹ 208 Cr
- Current price
- ₹ 169.05
- 52-week high / low
- ₹ 244 / 126
- Stock P/E
- 27.9
- Book value
- ₹ 43.1
- Dividend yield
- 0.30%
- ROCE
- 18.3%
- ROE
- 15.7%
- Debt to equity
- 0.30
- Sales growth (3 yrs)
- 24.7%
- Profit growth (3 yrs)
- 14.6%
- 1-year return
- -29.4%
About Sanjivani Paranteral Limited
Sanjivani Paranteral Limited operates as a pharmaceutical company in India. The company manufactures pharmaceutical products in the form of oral solids, small volume parenteral, and sterile powder formulations for various therapeutic areas, including central nervous system, cardiovascular system, antibiotics, gastroenterological, anti-diabetics, and anti-allergic. It also offers soft gels, such as multivitamins; topicals comprising corticosteroids, antiseptics, NSAIDs, anti-fungal, and anti-bacterial; nasal sprays; liquid and dry powder injections covering antibiotics, anti-emetic, NSAID and analgesic, antimalarial, and proton pump inhibitor and H2 receptor antagonist; capsules and tablets, including antibiotic, antifungal, anticonvulsant, multivitamins, and NSAID and analgesic; dry syrups; and ear/eye drops. In addition, the company exports its products. Sanjivani Paranteral Limited was incorporated in 1994 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 18 | 16 | 22 | 13 | 24 |
| Operating profit | 3 | 2 | 4 | 2 | 4 |
| Net profit | 2 | 2 | 3 | 1 | 2 |
| EPS (₹) | 1.46 | 1.33 | 2.21 | 0.49 | 2.03 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.